Deliyanti, Devy
20  results:
Search for persons X
?
2

Limiting neuronal nogo receptor 1 signaling during experime..:

Lee, Jae Young ; Kim, Min Joung ; Thomas, Speros...
Lee , J Y , Kim , M J , Thomas , S , Oorschot , V , Ramm , G , Aui , P M , Sekine , Y , Deliyanti , D , Wilkinson-Berka , J , Niego , B , Harvey , A R , Theotokis , P , McLean , C , Strittmatter , S M & Petratos , S 2019 , ' Limiting neuronal nogo receptor 1 signaling during experimental autoimmune encephalomyelitis preserves axonal transport and abrogates inflammatory demyelination ' , The Journal of Neuroscience , vol. 39 , no. 28 , pp. 5562-5580 . https://doi.org/10.1523/JNEUROSCI.1760-18.2019.  , 2019
 
?
4

Nrf2 activation is a potential therapeutic approach to atte..:

Deliyanti, Devy ; Alrashdi, Saeed F ; Tan, Sih Min...
Deliyanti , D , Alrashdi , S F , Tan , S M , Meyer , C , Ward , K W , de Haan , J B & Wilkinson-Berka , J L 2018 , ' Nrf2 activation is a potential therapeutic approach to attenuate diabetic retinopathy ' , Investigative Ophthalmology and Visual Science , vol. 59 , no. 2 , pp. 815-825 . https://doi.org/10.1167/iovs.17-22920.  , 2018
 
?
5

Foxp3 + Tregs are recruited to the retina to repair patholo..:

Deliyanti, Devy ; Talia, Dean M ; Zhu, Tong...
Deliyanti , D , Talia , D M , Zhu , T , Maxwell , M J , Agrotis , A , Jerome , J R , Hargreaves , E M , Gerondakis , S , Hibbs , M L , Mackay , F & Wilkinson-Berka , J L 2017 , ' Foxp3 + Tregs are recruited to the retina to repair pathological angiogenesis ' , Nature Communications , vol. 8 , no. 1 , 748 . https://doi.org/10.1038/s41467-017-00751-w.  , 2017
 
?
 
?
8

Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency ..:

Lee, Jae Young ; Kim, Min Joung ; Deliyanti, Devy...
Lee , J Y , Kim , M J , Deliyanti , D , Azari , M F , Rossello , F , Costin , A , Ramm , G , Stanley , E G , Elefanty , A G , Wilkinson-Berka , J L & Petratos , S 2017 , ' Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination ' , EBioMedicine , vol. 25 , pp. 122-135 . https://doi.org/10.1016/j.ebiom.2017.10.016.  , 2017
 
?
9

The potential of anti-VEGF (Vasotide) by eye drops to treat..:

Wilkinson-Berka, Jennifer L ; Deliyanti, Devy
Wilkinson-Berka , J L & Deliyanti , D 2016 , ' The potential of anti-VEGF (Vasotide) by eye drops to treat proliferative retinopathies ' , Annals of Translational Medicine , vol. 4 , no. Suppl 1 , S41 . https://doi.org/10.21037/atm.2016.10.27.  , 2016
 
?
11

FT011, a novel cardiorenal protective drug, reduces inflamm..:

Deliyanti, Devy ; Zhang, Yuan ; Khong, Fay Lin...
Deliyanti , D , Zhang , Y , Khong , F L , Berka , D , Stapleton , D I , Kelly , D J & Wilkinson-Berka , J 2015 , ' FT011, a novel cardiorenal protective drug, reduces inflammation, gliosis and vascular injury in rats with diabetic retinopathy ' , PLoS ONE , vol. 10 , no. 7 , e0134392 . https://doi.org/10.1371/journal.pone.0134392.  , 2015
 
?
12

Inhibition of NOX1/4 with GKT137831: a potential novel trea..:

Deliyanti, Devy ; Wilkinson-Berka, Jennifer
Deliyanti , D & Wilkinson-Berka , J 2015 , ' Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina ' , Journal of Neuroinflammation , vol. 12 , no. 1 (Art. No: 136) , pp. 1 - 13 . https://doi.org/10.1186/s12974-015-0363-z.  , 2015
 
?
14

NADPH Oxidase, NOX1, Mediates Vascular Injury in Ischemic R..:

Wilkinson-Berka, Jennifer L ; Deliyanti, Devy ; Rana, Indrajeetsinh...
Wilkinson-Berka , J L , Deliyanti , D , Rana , I , Miller , A G , Agrotis , A , Armani , R , Szyndralewiez , C , Wingler , K , Touyz , R M , Cooper , M E , Jandeleit-Dahm , K A & Schmidt , H H H W 2014 , ' NADPH Oxidase, NOX1, Mediates Vascular Injury in Ischemic Retinopathy ' , Antioxidants & Redox Signaling , vol. 20 , no. 17 , pp. 2726-2740 . https://doi.org/10.1089/ars.2013.5357.  , 2014
 
1-15